Phase I trial of SAR 279356 in volunteers.
Phase of Trial: Phase I
Latest Information Update: 15 Feb 2012
At a glance
- Drugs F-598 (Primary)
- Indications Methicillin-resistant Staphylococcus aureus infections
- Focus Adverse reactions
- 14 Sep 2010 Status changed from planning to recruiting.
- 22 Dec 2009 New trial record
- 14 Dec 2009 This trial will be initiated in 2010 according to a sanofi-aventis and Alopexx Pharmaceuticals media release.